follow mell following
follow mell 2017 Aug 31, 9:41am
482 views 12 comments
Mell, for me, the single most important parameter that determines whether I should pay attention to a stock tip is HOW you first heard about the stock)s) in question.How did ARRY come to your attention? what date?How did VCEL come to your attention? what date?
Hey mell, not trying to rain on your parade, but I think it was you who frequently touted OXGN. Whatever happened with that one, it seems to have went bust.I do like this model, though. We used to use it in handicapping, if you could average your plays @ +200, you only need to hit 35% to be profitable.So if you're gunning for 2x-3x gains, you can afford two out of three to go bust, and still turn a profit.
Was oxgn the company with the diabetes drug, or something similar?
Sad because there is a real need and I have been toying with the idea of putting a little into MNKD, who are now the only company for inhaled insulin (Affreza goes into the lungs which I consider inferior to GNBTs buccal delivery due to more side-effect, but there are so many needle-phobes out there that they may have a decent market soon). If MNKD can ramp up Affreza sales and make it affordable/fully reimbursable, why would people choose the needle?